The stock of Firstsource Solutions has given downward sloping trendline breakout on Tuesday formed by connecting swing highs from December 4, 2018. The breakout was supported by justifiable volumes. Additionally, the stock formed a sizeable bullish candle on breakout day, which adds strength to the breakout.

Sadbhav Engineering Limited was picked by our Bollinger Band squeeze scanner which suggests that the stock is near a consolidation breakout.

As Nifty is consolidating since last four days between 11,550 and 11,710, going ahead, a breakout from this trading range would lead to a sharper move on either side. Watch these levels closely and if it closes below or above the support and resistance levels, it will lead to explosive moves. Stocks in news: Majesco, IndusInd Bank, Vodafone Idea, Avenue Supermarts, Praj Industries, Tata Sponge Iron.

Considering the early action in SGX Nifty and the Asian peers, it appears that the Indian benchmark indices are expected to open lower. Digging deeper, scaring the market participants the most is the global growth forecast from IMF as it cut global growth outlook amidst global trade tensions. Also, the US President Donald Trump threatened to impose tariffs on $11 billion worth of European Union (EU) products and the latest statement from the EU suggests these countries will retaliate. At the time of writing, SGX Nifty was trading around 11,709 levels down by 40 points.

Post lunch recovery sends benchmark indices back to their highs. The BSE Sensex closed at 38,939.22, up by 238.69 points or 0.62 per cent, while Nifty50 ended the day at 11,671.95, up by 67.45 points or 0.58 per cent on Tuesday.

The stocks that are likely to witness significant movement on the bourses on April 10 are Bharat Forge, Sundram Fasteners, Tech Mahindra, GSFC and Praj Industries

Gujarat State Fertilizers and Chemicals (GSFC) informed the bourses today that it will start annual shutdown of Ammonia - IV plant of Baroda Unit from April 13, 2019 for a period of 50 days.

Shilpa Medicare has received a tentative approval for its ANDA , Bortezomib for Injection, 3.5mg/vial from the USFDA. Bortezomib for Injection, 3.5mg/vial is a generic equivalent of reference listed drug (RLD), VELCADE used in the treatment of patients with multiple myeloma and Mantle Cell Lymphoma as recommended in the label approved by the FDA.According to IQVIA MAT Q4 2018 data, the US market for Bortezomib for Injection, 3.5mg/vial is approximately US$609 million.

Nomination is often considered to be the first step towards estate planning. However, just having a nomination alone is not enough for wealth distribution. Let’s find out crucial aspects of effective estate planning.

Sobha Limited announced its fourth quarter business update for FY19, on Monday. The company clocked a sales volume of 1,129,268 square feet in Q4FY19 worth Rs. 920.5 crore. The sales value for the quarter was up by nearly 13.3 per cent from the corresponding quarter of the previous year.